Clinical Trials Browser

Completed × NETWORK × Recurrent Uterine Corpus Carcinoma × Clear all

NCT01164735 2024-08-14

Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Recurrent Uterine Corpus Carcinoma

NCT00063999 2021-10-19

Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Phase 3 Completed

1,381 enrolled 12 charts

Recurrent Uterine Corpus Carcinoma